Corrigendum: RIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium (Cellular and Molecular Immunology (2015) 12 (96-106) DOI: 10.1038/cmi.2014.34);rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium

Cellular and Molecular Immunology

Volumn 12, Issue 1, 2015, Pages 96-106

  Kaur, Gurpreet ^a   Chitradevi, Charu ^a   Bansal, Anju ^a  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

gene expression; GroEL; IL 22; immunity; vaccine

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; RECOMBINANT CYTOKINE; RECOMBINANT GROEL PROTEIN; RECOMBINANT INTERLEUKIN 22; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; CHAPERONIN 60; CYTOKINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL LOAD; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HISTOPATHOLOGY; IMMUNOGENICITY; IMMUNOSTIMULATION; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MONOTHERAPY; MOUSE; NONHUMAN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; TH1 CELL; TH2 CELL; TYPHOID FEVER; ANIMAL; BAGG ALBINO MOUSE; HUMORAL IMMUNITY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; SALMONELLA ENTERICA SEROVAR TYPHI; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA INFECTIONS, ANIMAL;

ANIMALIA; MURINAE; MUS; SALMONELLA; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACTERIAL PROTEINS; CHAPERONIN 60; CYTOKINES; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INTERLEUKINS; MICE; MICE, INBRED BALB C; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; TH1 CELLS; TH2 CELLS; TYPHOID FEVER;

EID: 84920520506     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/cmi.2015.114     Document Type: Erratum

References (55)

1. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Org 2004; 82: 346-353
2. Mittrucker HW, Kaufmann SH. Immune response to infection with Salmonella typhimurium in mice. J Leuk Biol 2000; 67: 457-463
3. The World Health report 1996-fighting disease, fostering development. World Health Forum 1997; 18: 1-8
4. Kossaczka Z, Lin FY, Ho VA, Thuy NT, van Bay P, Thanh TC, et al. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2-To 4-year-old children in Vietnam. Infect Immun 1999; 67: 5806-5810
5. Fraser A, Goldberg E, Acosta CJ, Paul M, Leibovici L. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev 2007; (3): CD001261
6. Marathe SA, Lahiri A, Negi VD, Chakravortty D. Typhoid fever & vaccine development: a partially answered question. Indian J Med Res 2012; 135: 161-169
7. Robert J. Evolution of heat shock protein and immunity. Dev Comp Immunol 2003; 27: 449-464
8. Pockley AG. Heat shock proteins as regulators of the immune response. Lancet 2003; 362: 469-476
9. Kaufmann SH. Heat shock proteins and the immune response. Immunol Today 1990; 11: 129-136
10. Young DB. Stress proteins and the immune response. Anton Leeuw 1990; 58: 203-208
11. Perez-Perez GI, Thiberge JM, Labigne A, Blaser MJ. Relationship of immune response to heat-shock protein A and characteristics of Helicobacter pylori-infected patients. J Infect Dis 1996; 174: 1046-1050
12. Gomez FJ, Allendoerfer R, DeepeGSJr. Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect Immun 1995; 63: 2587-2595
13. Noll A, Autenrieth IB. Immunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 immunostimulating complexes or Yersinia HSP60 plus interleukin-12. Infect Immun 1996; 64: 2955-2961
14. Wilhelm V, Soza C, Martinez R, Rosemblatt M, Burzio LO, Valenzuela PD. Production and immune response of recombinant Hsp60 and Hsp70 from the salmon pathogen Piscirickettsia salmonis. Biol Res 2005; 38: 69-82
15. Paliwal PK, Bansal A, Sagi SS, Mustoori S, Govindaswamy I. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice. Clin Immunol 2008; 126: 89-96
16. Bansal A, Paliwal PK, Sagi SS, Sairam M. Effect of adjuvants on immune response and protective immunity elicited by recombinant Hsp60 (GroEL) of Salmonella typhi against S. typhi infection. Mol Cell Biochem 2010; 337: 213-221
17. Cheng G, Zhao X, Yan W, Wang W, Zuo X, Huang K, et al. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-And-mouth disease virus in swine, and an effective stimulus of in vivo immune response. Vaccine 2007; 25: 5199-5208
18. Hung LH, Li HP, Lien YY, Wu ML, Chaung HC. Adjuvant effects of chicken interleukin-18 in avian Newcastle disease vaccine. Vaccine 2010; 28: 1148-1155
19. Arulanandam BP, Lynch JM, Briles DE, Hollingshead S, Metzger DW. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect Immun 2001; 69: 6718-6724
20. Taylor CE. Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses. Infect Immun 1995; 63: 3241-3244
21. Disis ML, Bernhard H, Shiota FM, Hand SL, Gralow JR, Huseby ES, et al. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood 1996; 88: 202-210
22. Kayamuro H, Yoshioka Y, Abe Y, Arita S, Katayama K, Nomura T, et al. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J Virol 2010; 84: 12703-12712
23. Wolk K, Sabat R. Interleukin-22: a novel T-And NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 2006; 17: 367-380
24. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008; 14: 275-281
25. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008; 14: 282-289
26. Adel Galal El-Shemi MA, Kensara OA, Ashshi AM. Interleukin-22 therapy attenuates the development of acute pancreatitis in rats. J Clin Med Res 2011; 3: 82-88
27. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007; 27: 647-659
28. Schulz SM, Kohler G, Schutze N, Knauer J, Straubinger RK, Chackerian AA, et al. Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17. J Immunol 2008; 181: 7891-7901
29. Dhiman R, Indramohan M, Barnes PF, Nayak RC, Paidipally P, Rao LV, et al. IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. J Immunol 2009; 183: 6639-6645
30. Kaur G, Sts C, Nimker C, Singh M, Saraswat D, Saxena S, et al. Coexpression of S. Typhi GroEL and IL-22 gene augments immune responses against Salmonella infection. Immunol Cell Biol 2013; 91: 642-651
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
32. Schwager I, Jungi TW. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood 1994; 83: 152-160
33. Urbaschek B, Becker K, Ditter B, Urbaschek R. Quantification of endotoxin and sample-related interferences in human plasma and cerebrospinal fluid by using a kinetic Limulus amoebocyte lysate microtiter test. In: Microbiology. Washington, DC: American Society for Microbiology, 1985: 39-42
34. Urbaschek R, Mannel DN, Urbanczik R. Isoniazid protects mice against endotoxin lethality without influencing tumor necrosis factor synthesis and release. Antimicrob Agents Chemother 1991; 35: 1666-1668
35. Cai X, Wang J, Wang Y, Yang Y, Gao J, Fu W, et al. Expression, purification and characterization of recombinant human interleukin-22 in Pichia pastoris. Mol Biol Rep 2010; 37: 2609-2613
36. Tang W, Chen G, Gu Q, Pan J, Wu W. Expression, purification and identification of recombinant mouse interleukin 21 protein in E. coli. Cell Mol Immunol 2006; 3: 311-315
37. Zhang X, Goncalves R, Mosser DM. The isolation and characterization of murine macrophages. In: Coligan JE (ed.) Current Protocols in Immunology. New York: Wiley, 2008: Chapter 14: Unit 14 11
38. Zindl CL, Lai JF, Lee YK, Maynard CL, Harbour SN, OuyangWet al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci USA 2013; 110: 12768-12773
39. Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunol Rev 2013, 252: 116-132
40. Pociask DA, Scheller EV, Mandalapu S, McHugh KJ, Enelow RI, Fattman CL, et al. IL-22 is essential for lung epithelial repair following influenza infection. Am J Pathol 2013; 182: 1286-1296
41. Wu B, Zou Q, Hu Y, Wang B. Interleukin-22 as a molecular adjuvant facilitates IL-17-producing CD8 T cell responses against a HBV DNA vaccine in mice. Hum Vaccines Immunother 2013; 9: 2133-2141
42. Hezarjaribi HZ, Ghaffarifar F, Dalimi A, Sharifi Z, Jorjani O. Effect of IL-22 on DNA vaccine encoding LACK gene of Leishmania major in BALB/c mice. Exp Parasitol 2013; 134: 341-348
43. Lo WF, Dunn CD, Ong H, Metcalf ES, Soloski MJ. Bacterial and host factors involved in the major histocompatibility complex class Ibrestricted presentation of Salmonella Hsp 60: novel pathway. Infect Immun 2004; 72: 2843-2849
44. Salerno-Goncalves R, Pasetti MF, Sztein MB. Characterization of CD81 effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J Immunol 2002; 169: 2196-2203
45. Salerno-Goncalves R, Wyant TL, Pasetti MF, Fernandez-Vina M, Tacket CO, Levine MM, et al. Concomitant induction of CD41 and CD81 T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA. J Immunol 2003; 170: 2734-2741
46. Mittrucker HW, Raupach B, Kohler A, Kaufmann SH. Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection. J Immunol 2000; 164: 1648-1652
47. Mastroeni P, Simmons C, Fowler R, Hormaeche CE, Dougan G. Igh-62/2 (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun 2000; 68: 46-53
48. Kaufmann SH. Immunity to intracellular bacteria. Annu Rev Immunol 1993; 11: 129-163
49. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009; 27: 519-550
50. Widmer MB, Grabstein KH. Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor. Nature 1987; 326: 795-798
51. Appelberg R, Castro AG, Pedrosa J, Minoprio P. Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice. Immunology 1994; 82: 361-364
52. Dinarello CA. Role of interleukin-1 in infectious diseases. Immunol Rev 1992; 127: 119-146
53. Leal IS, Smedegard B, Andersen P, Appelberg R. Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine. Infect Immun 1999; 67: 5747-5754
54. Nagalakshmi ML, Rascle A, Zurawski S, Menon S, de Waal Malefyt R. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int Immunopharmacol 2004; 4: 679-691
55. Mastroeni P. Immunity to systemic Salmonella infections. Curr Mol Med 2002; 2: 393-406